Analyst Reco. Terns Pharmaceuticals, Inc.

Equities

TERN

US8808811074

Market Closed - Nasdaq Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
6.035 ^USD	-14.03%		+0.58%	-7.01%

May. 13	Terns Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 08	Terns Pharmaceuticals, Inc. Announces Executive Changes	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating	Mar. 27	MT
JMP Securities Cuts Terns Pharmaceuticals Price Target to $15 From $17, Maintains Market Outperform Rating	Mar. 18	MT
BMO Capital Adjusts Price Target on Terns Pharmaceuticals to $19 From $18, Maintains Outperform Rating	Mar. 15	MT
Jefferies Adjusts Terns Pharmaceuticals Price Target to $22 From $18, Maintains Buy Rating	Jan. 18	MT
HC Wainwright Adjusts Price Target on Terns Pharmaceuticals to $5.50 From $8, Maintains Neutral Rating	Jan. 10	MT
Mizuho Adjusts Price Target on Terns Pharmaceuticals to $10 From $17, Maintains Buy Rating	Nov. 27	MT
HC Wainwright Adjusts Price Target on Terns Pharmaceuticals to $8 From $11, Keeps Neutral Rating	23-08-10	MT
Mizuho Ups Price Target on Terns Pharmaceuticals to $17 From $16, Keeps Buy Rating	23-08-09	MT
Mizuho Securities Initiates Terns Pharmaceuticals With Buy Rating, $16 Price Target	23-06-22	MT
Jefferies Initiates Terns Pharmaceuticals at Buy With $18 Price Target	23-06-07	MT
Roth MKM Initiates Terns Pharmaceuticals at Buy With $23 Price Target	23-05-31	MT
JPMorgan Adjusts Price Target on Terns Pharmaceuticals to $10 From $9, Maintains Neutral Rating	23-05-16	MT
BMO Capital Initiates Terns Pharmaceuticals at Outperform With $18 Price Target	23-05-08	MT
JPMorgan Adjusts Price Target on Terns Pharmaceuticals to $9 From $6, Maintains Neutral Rating	23-03-29	MT
HC Wainwright Adjusts Terns Pharmaceuticals' Price Target to $11 From $7, Keeps Neutral Rating	23-03-29	MT
JMP Securities Starts Terns Pharmaceuticals at Market Outperform With $17 Price Target	23-02-14	MT
UBS Initiates Coverage on Terns Pharmaceuticals With Buy Rating, $19 Price Target	23-02-07	MT
HC Wainwright Boosts Price Target on Terns Pharmaceuticals to $7 From $6, Maintains Neutral Rating	22-12-29	MT
Goldman Sachs Adjusts Price Target on Terns Pharmaceuticals to $14 From $9, Maintains Buy Rating	22-12-20	MT
Goldman Sachs Adjusts Price Target on Terns Pharmaceuticals to $9 From $4, Reiterates Buy Rating	22-09-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Terns Pharmaceuticals, Inc.

Equities

TERN

US8808811074

Analyst Reco.

Filters